Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2026)

Indivior Pharmaceuticals' Net Margin history runs 3 years deep, the most recent figure standing at 28.08% for Q1 2026.

• In Q1 2026, Net Margin rose 1003.0% year-over-year to 28.08%; the TTM figure through Mar 2026 stood at 19.44% (up 2004.0% YoY), while the FY2025 annual figure was 16.95%, up 1636.0% from the prior year.
• Net Margin was 28.08% for Q1 2026 at Indivior Pharmaceuticals, down from 28.49% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 28.49% in Q4 2025 to a low of 32.78% in Q2 2024.
• Historically, Net Margin has averaged 10.8% across 3 years, with a median of 13.38% in 2025.
• Biggest YoY gain for Net Margin was 3874 bps in 2025; the steepest drop was 379 bps in 2025.
• A 3-year view of Net Margin shows it stood at 7.02% in 2024, then surged by 306 bps to 28.49% in 2025, then slipped by 1 bps to 28.08% in 2026.
• The last three Net Margin figures came in at 28.08% (Q1 2026), 28.49% (Q4 2025), and 13.38% (Q3 2025), per Business Quant data.